Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 50.24% | 25.53% | -24.15% | -71.29% | -91.71% |
| Total Depreciation and Amortization | 19.07% | 37.60% | 59.69% | 71.17% | 85.98% |
| Total Amortization of Deferred Charges | 1,579.65% | 1,321.47% | 676.89% | 1,607.32% | -- |
| Total Other Non-Cash Items | -174.33% | -170.73% | -184.64% | -202.78% | -- |
| Change in Net Operating Assets | 261.45% | 226.04% | -121.05% | -503.91% | -179.80% |
| Cash from Operations | 80.30% | 44.96% | -37.51% | -62.25% | -123.75% |
| Capital Expenditure | 94.82% | 85.89% | 66.52% | -2,945.60% | -17,372.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.90% | 29.73% | 3.09% | 14.03% | -- |
| Cash from Investing | 75.73% | 67.05% | 45.93% | -241.03% | -25,931.82% |
| Total Debt Issued | -93.61% | -93.69% | -93.70% | 187.84% | 6,528.42% |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.10% | -101.99% | -101.95% | 46.70% | 205.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.97% | -197.19% | -201.54% | -105.46% | 4,387.23% |